{"id":24091,"date":"2014-05-30T12:51:17","date_gmt":"2014-05-30T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=24091"},"modified":"2018-04-14T02:10:23","modified_gmt":"2018-04-14T07:10:23","slug":"24091","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/24091\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 30 de maio de 2014"},"content":{"rendered":"

vers\u00e3o impressa<\/a><\/p>\n

***********************************
\nBrakke Consulting's
\nNot\u00edcias e notas sobre sa\u00fade animal de 30 de maio de 2014
\n<\/strong>Copyright \u00a9 Brakke Consulting, Inc.
\n 
\nEditor: Lynn Fondon DVM MBA
\n************************************
\nNAS NOTICIAS:
\n 
\nNovidades da Brakke Consulting<\/u>
\nCanal OTC
\n 
\nnot\u00edcias de ganhos<\/u>
\nKrka
\n 
\noutras not\u00edcias
\n<\/u>Boehringer Ingelheim Vetmedica
\nGera\u00e7\u00f5es
\nMarcas Hillshire
\norgulho do peregrino
\nPuri Core
\nRoyal Canin
\nSelecione os senhores
\nSire Lodge
\nAlimentos Tyson
\nVGX Sa\u00fade Animal
\n 
\n************************************
\nBRAKKE CONSULTING, INC.
\nENTENDENDO O MERCADO DE BOLSA<\/strong><\/p>\n

Se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou voc\u00ea distribui nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre os detalhes dos canais OTC de distribui\u00e7\u00e3o. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas l\u00e1 e as oportunidades existentes, entre em contato com nosso escrit\u00f3rio em Dallas ou Joel Adamson em jadamson@brakkeconsulting.com<\/a> .
\n 
\nwww.BrakkeConsulting.com<\/a>
\n 
\n************************************
\nRELEASES DE RESULTADOS DA EMPRESA
\n 
\n> Krka reportou resultados financeiros para o primeiro trimestre de 2014. As vendas de produtos de sa\u00fade animal foram de 10,9 milh\u00f5es de euros ($14,9 milh\u00f5es), inalteradas em rela\u00e7\u00e3o ao per\u00edodo compar\u00e1vel do ano anterior. (Farm\u00e1cia Animal)   
\n 
\n***********************************
\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA
\n 
\n> A Boehringer Ingelheim Vetmedica, Inc., anunciou o lan\u00e7amento da ULTRA Fel-O-Vax, a primeira linha de vacinas de \u00bd mL para gatos. A linha de vacinas ULTRA Fel-O-Vax est\u00e1 dispon\u00edvel em combina\u00e7\u00f5es essenciais e n\u00e3o essenciais. (comunicado de imprensa da empresa) 
\n 
\n> A Royal Canin introduziu a An\u00e1lise Gen\u00e9tica de Sa\u00fade, um teste que identifica a composi\u00e7\u00e3o espec\u00edfica de ra\u00e7as caninas, bem como marcadores gen\u00e9ticos que apontam para poss\u00edveis problemas de sa\u00fade que podem surgir no futuro. (DVM360) 
\n 
\n> A Inovio Pharmaceuticals, Inc. anunciou que sua subsidi\u00e1ria de propriedade do 90%, VGX Animal Health, Inc., concluiu um acordo para a venda de seus ativos de sa\u00fade animal para a Plumbline Life Sciences, Inc. da Cor\u00e9ia. Os ativos transferidos incluem uma licen\u00e7a exclusiva com a Inovio para aplica\u00e7\u00f5es em animais de sua tecnologia de horm\u00f4nio liberador do horm\u00f4nio de crescimento (GHRH) e vacinas de DNA animal, al\u00e9m de uma licen\u00e7a n\u00e3o exclusiva para sistemas de entrega de eletropora\u00e7\u00e3o da Inovio. A VGX Animal Health receber\u00e1 $2 milh\u00f5es em dinheiro em pagamentos m\u00faltiplos e 20% das a\u00e7\u00f5es em circula\u00e7\u00e3o da Plumbline. (Observa\u00e7\u00e3o do mercado) 
\n 
\n> A PuriCore lan\u00e7ou o NovaZo Hydrogel, um curativo de hidrogel para uso em animais de companhia e de grande porte de todas as esp\u00e9cies. (DVM360) 
\n 
\n> A Pilgrim's Pride Corporation anunciou uma proposta para adquirir a The Hillshire Brands Company por $45,00 por a\u00e7\u00e3o em dinheiro, em uma transa\u00e7\u00e3o avaliada em $6,4 bilh\u00f5es. No final da semana, a Tyson Foods, Inc. anunciou sua pr\u00f3pria oferta para adquirir a The Hillshire Brands Company por $50,00 por a\u00e7\u00e3o em dinheiro. (Alimentos) 
\n 
\n> A Select Sires chegou a um acordo para comprar a organiza\u00e7\u00e3o de insemina\u00e7\u00e3o artificial GenerVations Inc. e seu alojamento de touros e instala\u00e7\u00e3o de produ\u00e7\u00e3o, Sire Lodge Inc. Os termos financeiros n\u00e3o foram divulgados. (Alimentos)
\n 
\n***********************************
\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL
\n 
\n> EUA \u2013 PEDV Uma fazenda em Indiana sofreu um segundo surto de v\u00edrus da diarr\u00e9ia epid\u00eamica su\u00edna, uma doen\u00e7a que se pensava conferir imunidade ao atacar um rebanho, protegendo as fazendas contra surtos adicionais. Dez por cento da popula\u00e7\u00e3o su\u00edna dos EUA foi exterminada pelo v\u00edrus, e as indica\u00e7\u00f5es de que o v\u00edrus pode reinfectar os rebanhos sugerem que podem ocorrer perdas maiores e que o surto pode ser mais dif\u00edcil de parar do que se pensava anteriormente. (AVMA SmartBrief \u2013 Reuters)
\n 
\n> A Organiza\u00e7\u00e3o das Na\u00e7\u00f5es Unidas para a Alimenta\u00e7\u00e3o e a Agricultura (FAO) e a Organiza\u00e7\u00e3o Mundial da Sa\u00fade Animal (OIE) comprometeram-se a intensificar a sua colabora\u00e7\u00e3o existente para controlar as doen\u00e7as animais, garantir a seguran\u00e7a dos alimentos de origem animal e promover o com\u00e9rcio seguro. As duas organiza\u00e7\u00f5es afirmaram que iriam refor\u00e7ar a sua parceria em \u00e1reas priorit\u00e1rias que incluem a resposta conjunta \u00e0s crises de sa\u00fade animal e programas para prevenir e controlar a febre aftosa, a peste dos pequenos ruminantes, a peste su\u00edna africana, a raiva, a gripe zoon\u00f3tica e a resist\u00eancia antimicrobiana. Em coopera\u00e7\u00e3o com a Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS), a FAO e a OIE afirmaram que planeiam concentrar-se na monitoriza\u00e7\u00e3o da utiliza\u00e7\u00e3o respons\u00e1vel de produtos antimicrobianos e farmac\u00eauticos. Trabalhar\u00e3o tamb\u00e9m para fortalecer os sistemas veterin\u00e1rios nacionais. (Alimentos)
\n 
\n************************************
\nPONTO DE VISTA DA BRAKKE CONSULTORIA
\n 
\nSendo esta uma semana comercial curta, o boletim informativo tamb\u00e9m \u00e9 mais curto do que o normal com not\u00edcias do setor. Tenho viajado pelo Centro-Oeste nas \u00faltimas duas semanas e achei o clima agrad\u00e1vel, com a maioria das \u00e1reas precisando de chuva adicional. Quase todas as culturas est\u00e3o plantadas e aguardam o tempo quente e a chuva.<\/p>\n

Conforme relatado em diversas publica\u00e7\u00f5es, 2014 come\u00e7ou lento devido \u00e0s condi\u00e7\u00f5es clim\u00e1ticas dif\u00edceis no primeiro trimestre. Parece que abril e maio ser\u00e3o bons meses na \u00e1rea dos animais de companhia. No entanto, os mercados de bovinos e su\u00ednos s\u00e3o desafiadores devido ao n\u00famero reduzido de animais. Em geral, aqueles que visitamos nas \u00faltimas duas semanas est\u00e3o otimistas em rela\u00e7\u00e3o a 2014, mas compartilham preocupa\u00e7\u00f5es gerais sobre se as vendas perdidas no primeiro trimestre ser\u00e3o recuperadas.<\/p>\n

Tenha um \u00f3timo fim de semana!! Parece que o ver\u00e3o finalmente chegou!<\/p>\n

Ron Brakke
\n 
\n**********************************
\nProblemas para visualizar esta newsletter? Voc\u00ea pode visualiz\u00e1-lo online em www.BrakkeConsulting.com<\/a>
\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.
\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.
\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em www.brakkeconsulting.com<\/a>.
\n 
\nBrakke Consulting, Inc.
\n12005 Ford Rd., Suite 530
\nDallas, TX 75234 EUA<\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

vers\u00e3o impressa *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 30 de maio de 2014 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA *************************************** NO NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias sobre ganhos do canal OTC Krka outras not\u00edcias Boehringer Ingelheim Vetmedica GenerVations Hillshire Brands Pilgrim's Pride PuriCore Royal Canin Select Sires Sire Lodge Tyson Foods VGX Animal Health ****************** ****************** BRAKKE CONSULTING, INC. ENTENDENDO O MERCADO DE COUNTER Se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou se voc\u00ea est\u00e1 distribuindo no Canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade \u00e0s empresas que buscam aprender mais sobre os detalhes dos canais OTC de distribui\u00e7\u00e3o. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas neles e as oportunidades existentes, entre em contato com nosso escrit\u00f3rio em Dallas ou com Joel Adamson em jadamson@brakkeconsulting.com. www.BrakkeConsulting.com ************************************ DIVULGA\u00c7\u00d5ES DE RESULTADOS DA EMPRESA > Krka relatou resultados financeiros para no primeiro trimestre de 2014. As vendas de produtos de sa\u00fade animal foram de 10,9 milh\u00f5es de euros ($14,9 milh\u00f5es), inalteradas em rela\u00e7\u00e3o ao per\u00edodo compar\u00e1vel do ano anterior. (Animal Pharm) *********************************** COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA > Boehringer Ingelheim Vetmedica, Inc., anunciou o lan\u00e7amento da ULTRA Fel-O-Vax, primeira linha de vacinas de \u00bd mL para gatos. A linha de vacinas ULTRA Fel-O-Vax est\u00e1 dispon\u00edvel<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-24091","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/24091\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting’s Animal Health News & Notes for May 30, 2014 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news OTC Channel   earnings news Krka   other news Boehringer Ingelheim Vetmedica GenerVations Hillshire Brands Pilgrim’s Pride PuriCore Royal Canin Select Sires Sire Lodge Tyson Foods VGX Animal Health   ************************************ BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution. If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at jadamson@brakkeconsulting.com .   www.BrakkeConsulting.com   ************************************ COMPANY EARNINGS RELEASES   > Krka reported financial results for the first quarter of 2014. Animal health product sales were EUR 10.9 million ($14.9 million), unchanged from the comparable period in the prior year. (Animal Pharm)      *********************************** COMPANY NEWS RELEASES   > Boehringer Ingelheim Vetmedica, Inc., announced the launch of ULTRA Fel-O-Vax, the first ½ mL vaccine line for cats. The ULTRA Fel-O-Vax vaccine line is availableView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/24091\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-30T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:10:23+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/24091\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/24091\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for May 30, 2014\",\"datePublished\":\"2014-05-30T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:10:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/24091\/\"},\"wordCount\":896,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/24091\/\",\"url\":\"https:\/\/brakkeconsulting.com\/24091\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2014-05-30T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:10:23+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/24091\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/24091\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/24091\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for May 30, 2014\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/24091\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting’s Animal Health News & Notes for May 30, 2014 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news OTC Channel   earnings news Krka   other news Boehringer Ingelheim Vetmedica GenerVations Hillshire Brands Pilgrim’s Pride PuriCore Royal Canin Select Sires Sire Lodge Tyson Foods VGX Animal Health   ************************************ BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution. If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at jadamson@brakkeconsulting.com .   www.BrakkeConsulting.com   ************************************ COMPANY EARNINGS RELEASES   > Krka reported financial results for the first quarter of 2014. Animal health product sales were EUR 10.9 million ($14.9 million), unchanged from the comparable period in the prior year. (Animal Pharm)      *********************************** COMPANY NEWS RELEASES   > Boehringer Ingelheim Vetmedica, Inc., announced the launch of ULTRA Fel-O-Vax, the first ½ mL vaccine line for cats. The ULTRA Fel-O-Vax vaccine line is availableView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/24091\/","og_site_name":"Brakke Consulting Website","article_published_time":"2014-05-30T17:51:17+00:00","article_modified_time":"2018-04-14T07:10:23+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/24091\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/24091\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for May 30, 2014","datePublished":"2014-05-30T17:51:17+00:00","dateModified":"2018-04-14T07:10:23+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/24091\/"},"wordCount":896,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/24091\/","url":"https:\/\/brakkeconsulting.com\/24091\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2014-05-30T17:51:17+00:00","dateModified":"2018-04-14T07:10:23+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/24091\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/24091\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/24091\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for May 30, 2014"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=24091"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24091\/revisions"}],"predecessor-version":[{"id":25480,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24091\/revisions\/25480"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=24091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=24091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=24091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}